Funding Opportunity RFA-MH-18-400 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) seeks to leverage data from existing basic, clinical, and intervention research on suicide risk and behaviors as well as social media and healthcare records data, by encouraging the integration of existing data sets for novel secondary analyses aimed at identifying potential biological, experiential, and other predictors and moderators of suicide risk. The use of dimensional variables and inclusion of multiple levels of analyses is particularly encouraged. A secondary goal of this FOA is to support innovative projects that will generate foundational work for research studies on suicide-related behaviors that inform a Research Domain Criteria (RDoC) approach in this area. Projects supported by this FOA will help address gaps identified in the 2014 Prioritized Research Agenda for Suicide Prevention.

Notice NOT-DE-17-009 from the NIH Guide for Grants and Contracts

Notice NOT-DA-17-039 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-17-287 from the NIH Guide for Grants and Contracts. The objective of the NIA Academic Leadership Career Award (K07) is to provide support for senior investigators who have the expertise and leadership skills to enhance aging and geriatric research capacity within their academic institution.

Notice NOT-DA-17-037 from the NIH Guide for Grants and Contracts

Funding Opportunity PA-17-285 from the NIH Guide for Grants and Contracts. The purpose of this FOA is encourage applications that seek to examine processes of recovery and relapse in the treatment of Alcohol Use Disorders. Applications high in innovation and significance are highly encouraged that address the following potential topics: 1) Defining recovery; 2) Examining new and innovative methods to examine precipitants of relapse; 3) Understanding mechanisms of mutual help and recovery; 4) Evaluating recovery systems of care; and 5) Examining processes of extended treatment for AUD

Funding Opportunity PA-17-284 from the NIH Guide for Grants and Contracts. The purpose of this FOA is encourage applications that seek to examine processes of recovery and relapse in the treatment of Alcohol Use Disorders. Applications high in innovation and significance are highly encouraged that address the following potential topics: 1) defining recovery; 2) Examining new and innovative methods to examine precipitants of relapse; 3) Understanding mechanisms of mutual help and recovery; 4) Evaluating recovery systems of care; and 5) Examining processes of extended treatment for AUD

Notice NOT-HG-17-005 from the NIH Guide for Grants and Contracts

Notice NOT-DA-17-038 from the NIH Guide for Grants and Contracts

Notice NOT-AG-17-008 from the NIH Guide for Grants and Contracts

Funding Opportunity PA-17-282 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to invite applications to support innovative research to improve our understanding of innate and adaptive immune dysregulation caused by Type 2 diabetes mellitus (DM) and pre-diabetes that causes increased risk of latent tuberculosis (TB) re-activation and more severe active TB disease with more frequent treatment failure/relapse and death in the context of HIV co-infection.

Funding Opportunity PA-17-283 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications to support innovative research to improve our understanding of innate and adaptive immune dysregulation caused by Type 2 diabetes mellitus (DM) and pre-diabetes that causes increased risk of latent tuberculosis (TB) re-activation and more severe active TB disease with more frequent treatment failure/relapse and death in the context of HIV co-infection.

Notice NOT-RM-17-021 from the NIH Guide for Grants and Contracts

Notice NOT-RM-17-020 from the NIH Guide for Grants and Contracts

Notice NOT-RM-17-019 from the NIH Guide for Grants and Contracts

Notice NOT-RM-17-018 from the NIH Guide for Grants and Contracts

Funding Opportunity PA-17-279 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to fill scientific gaps needed to (a) inform HBV functional cure strategies by furthering our understanding of unique challenges impacting HBV and HIV co-infected hosts and (b) advance the discovery and development of novel HBV interventions that are safe and achieve a functional cure in HIV and HBV co-infected individuals.

Funding Opportunity PA-17-278 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to fill scientific gaps needed to (a) inform HBV functional cure strategies by furthering our understanding of unique challenges impacting HBV and HIV co-infected hosts and (b) advance the discovery and development of novel HBV interventions that are safe and achieve a functional cure in HIV and HBV co-infected individuals

Funding Opportunity RFA-DA-18-010 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage small businesses (SBCs) to develop next generation wearables and supporting mobile applications to identify digital biomarkers associated with reinitiating drug use and relapse, and create a model for just-in-time intervention.

Funding Opportunity RFA-HL-18-007 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) seeks applications for implementation research in the delivery of proven effective interventions for co-occurring heart, lung, blood, and sleep (HLBS) diseases and conditions among people living with HIV/AIDS. Proven effective interventions and management guidelines exist for co-morbid HLBS diseases and disorders for people living with HIV. However, these interventions have not been fully implemented among people living with HIV/AIDS and gaps in care remain. The intent of this FOA is to stimulate the use of late-stage T4 translation research and implementation science strategies to address barriers that impede the scale-up and application of proven effective interventions in community and clinical settings for the prevention, control, and treatment of co-morbid HLBS conditions for people living with HIV.